State Of Wisconsin Investment Board Unity Biotechnology, Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.15 - $6.3 $204,595 - $310,590	-49,300 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$3.42 - $6.36 $11,970 - $22,260	-3,500 Reduced 6.63%	49,300 $258,000
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $25,578 - $108,141	8,700 Added 19.73%	52,800 $183,000
Q1 2020 May 06, 2020	BUY	$5.0 - $7.6 $20,000 - $30,400	4,000 Added 9.98%	44,100 $256,000
Q3 2019 Nov 12, 2019	BUY	$5.62 - $9.63 $28,662 - $49,113	5,100 Added 14.57%	40,100 $245,000
Q2 2019 Aug 14, 2019	BUY	$7.59 - $10.21 $6,072 - $8,168	800 Added 2.34%	35,000 $332,000
Q1 2019 May 13, 2019	BUY	$7.65 - $16.66 $261,630 - $569,772	34,200 New	34,200 $277,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.